🔗 Permalink

Inventor profile of:

Jeffrey Browning

City:

Brookline, Massachusetts

Country:

United States

Published Applications:

Last publication date:

2020-03-26

Top Assignees for applications by Jeffrey Browning

The entities that hold a legal rights for patent applications filed by inventor Browning Jeffrey:

Biogen Idec MA Inc. 16 Cambridge, MA United States
THE FACULTY OF MEDICINE OF THE UNIVERSITY OF GENEVA 5 Geneva, Switzerland
BIOGEN MA INC. 3 Cambridge, MA United States
TOPOTARGET SWITZERLAND SA 3 Lausanne, Switzerland
NEW YORK UNIVERSITY 2 New York, NY United States
BIOGEN INC. 2 Cambridge, MA United States
THE FACULTY OF MEDICINE OF THE UNIV. OF GENEVA 1 Geneva, Switzerland
THE FACULTY OF MEDICINE OF THE UNIVERSITY OF GENEV 1 Geneva, Switzerland
UNIVERSITY OF CALIFORNIA 1 Oakland, CA United States
Biogen Idcc MA Inc. 1 Cambridge, MA United States
Apoxis SA 1 Epalingee, Switzerland

Recent patent applications by Browning Jeffrey

Jeffrey Browning from Brookline, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2020-03-26

US20200095305A1

Chemistry; metallurgy

METHODS OF MODULATING IMMUNE RESPONSES USING BCMA POLYPEPTIDE

#2 | 2018-09-27

US20180273605A1

Chemistry; metallurgy

Methods of modulating immune responses using BCMA polypeptide

#3 | 2015-05-21

US20150139992A1

Chemistry; metallurgy

Methods of treating autoimmune diseases using a B-cell maturation antigen (BCMA)

#4 | 2013-08-01

US20130196376A1

Chemistry; metallurgy

Method for increasing expression of active tumor necrosis factor receptor family member-Ig fusion proteins

#5 | 2012-08-23

US20120214687A1

Chemistry; metallurgy

Methods of screening for a compound that inhibits the interaction between BAFF and BCMA

#6 | 2011-01-06

US20110002924A1

Chemistry; metallurgy

TWEAK RECEPTOR AGONISTS AS ANTI-ANGIOGENIC AGENTS

#7 | 2010-10-14

US20100260761A1

Human necessities

ANTIBODIES SPECIFICALLY REACTIVE WITH A TUMOR NECROSIS FACTOR RELATED LIGAND

#8 | 2010-09-16

US20100233179A1

Chemistry; metallurgy

BAFF, inhibitors thereof and their use in the modulation of B-cell response

#9 | 2010-06-03

US20100136625A1

Human necessities

Method for the high level expression of active tumor necrosis receptor family member immunoglobulin fusion proteins

#10 | 2010-06-03

US20100136000A1

Human necessities

Treatment of follicular lymphomas using inhibitors of the LT pathway

#11 | 2009-09-08

US9767370

Active lymphotoxin-β receptor immunoglobulin chimeric protein compositions

#12 | 2008-01-10

US20080008714A1

Chemistry; metallurgy

TWEAK receptor agonists as anti-angiogenic agents

#13 | 2007-04-24

US10380611

Tweak receptor agonists as anti-angiogenic agents

#14 | 2006-12-21

US20060286111A1

Human necessities

Tumor necrosis factor related ligand

#15 | 2006-11-09

US20060252122A1

Human necessities

Tumor necrosis factor related ligand

#16 | 2006-10-31

US9245198

Tumor necrosis factor related ligand

#17 | 2006-08-01

US10077438

Methods of treatment by administering an anti-BCMA antibody

#18 | 2006-07-06

US20060147448A1

Chemistry; metallurgy

Treatment of immunological renal disorders by lymphotoxin pathway inhibitors

#19 | 2006-06-13

US9626219

Treatment of follicular lymphomas using inhibitors of the LT pathway

#20 | 2006-04-18

US10040281

Lymphotoxin-β, lymphotoxin-β complexes, pharmaceutical preparations and therapeutic uses thereof

#21 | 2006-04-13

US20060079457A1

Chemistry; metallurgy

BAFF, inhibitors thereof and their use in the modulation of B-cell response

#22 | 2005-08-04

US20050169924A1

Chemistry; metallurgy

BAFF, inhibitors thereof and their use in the modulation of B-cell response

#23 | 2005-06-02

US20050118629A1

Human necessities

Antibodies specifically reactive with a tumor necrosis factor related ligand

#24 | 2005-05-26

US20050112666A1

Human necessities

Tumor necrosis factor related ligand

#25 | 2005-05-12

US20050100548A1

Chemistry; metallurgy

BAFF, inhibitors thereof and their use in the modulation of B-cell response

#26 | 2005-03-22

US9911777

BAFF, inhibitors thereof and their use in the modulation of B-cell response

InventorID:

1167567 ⎘